531,723 Shares in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Bought by AMF Tjanstepension AB

AMF Tjanstepension AB bought a new position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) during the second quarter, according to the company in its most recent filing with the SEC. The firm bought 531,723 shares of the pharmacy operator’s stock, valued at approximately $6,431,000. AMF Tjanstepension AB owned 0.06% of Walgreens Boots Alliance as of its most recent SEC filing.

A number of other large investors also recently added to or reduced their stakes in the business. Blue Trust Inc. grew its holdings in Walgreens Boots Alliance by 115.7% in the 4th quarter. Blue Trust Inc. now owns 1,775 shares of the pharmacy operator’s stock worth $46,000 after acquiring an additional 952 shares during the last quarter. Ballentine Partners LLC bought a new stake in Walgreens Boots Alliance in the 4th quarter worth $201,000. International Assets Investment Management LLC grew its holdings in Walgreens Boots Alliance by 1,985.1% in the 4th quarter. International Assets Investment Management LLC now owns 889,546 shares of the pharmacy operator’s stock worth $23,226,000 after acquiring an additional 846,884 shares during the last quarter. Arkadios Wealth Advisors grew its holdings in Walgreens Boots Alliance by 5.4% in the 4th quarter. Arkadios Wealth Advisors now owns 23,486 shares of the pharmacy operator’s stock worth $613,000 after acquiring an additional 1,207 shares during the last quarter. Finally, Prime Capital Investment Advisors LLC boosted its stake in shares of Walgreens Boots Alliance by 20.3% during the 4th quarter. Prime Capital Investment Advisors LLC now owns 17,435 shares of the pharmacy operator’s stock valued at $455,000 after purchasing an additional 2,945 shares in the last quarter. Hedge funds and other institutional investors own 58.59% of the company’s stock.

Analysts Set New Price Targets

WBA has been the topic of several research analyst reports. Royal Bank of Canada reduced their price target on shares of Walgreens Boots Alliance from $22.00 to $13.00 and set a “sector perform” rating on the stock in a research report on Tuesday, July 2nd. Evercore ISI reduced their price target on shares of Walgreens Boots Alliance from $17.00 to $10.00 and set an “in-line” rating on the stock in a research report on Friday, June 28th. Bank of America reiterated an “underperform” rating and set a $11.00 price target (down previously from $22.00) on shares of Walgreens Boots Alliance in a research report on Friday, June 28th. TD Cowen reduced their price target on shares of Walgreens Boots Alliance from $35.00 to $22.00 and set a “buy” rating on the stock in a research report on Monday, July 1st. Finally, Barclays reduced their price target on shares of Walgreens Boots Alliance from $11.00 to $7.00 and set an “underweight” rating on the stock in a research report on Tuesday, July 23rd. Four investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, Walgreens Boots Alliance presently has an average rating of “Hold” and a consensus target price of $16.86.

Walgreens Boots Alliance Stock Down 1.2 %

Shares of NASDAQ WBA traded down $0.13 during midday trading on Wednesday, hitting $10.78. The stock had a trading volume of 14,101,852 shares, compared to its average volume of 15,745,724. The business’s 50 day moving average is $13.27 and its 200-day moving average is $17.56. The company has a market cap of $9.31 billion, a P/E ratio of -1.60, a PEG ratio of 0.80 and a beta of 0.72. Walgreens Boots Alliance, Inc. has a 52 week low of $10.62 and a 52 week high of $29.85. The company has a quick ratio of 0.31, a current ratio of 0.65 and a debt-to-equity ratio of 0.49.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Thursday, June 27th. The pharmacy operator reported $0.63 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.68 by ($0.05). The firm had revenue of $36.40 billion during the quarter, compared to the consensus estimate of $35.94 billion. Walgreens Boots Alliance had a positive return on equity of 12.63% and a negative net margin of 3.99%. The company’s quarterly revenue was up 2.8% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.00 EPS. As a group, analysts predict that Walgreens Boots Alliance, Inc. will post 2.87 EPS for the current year.

Walgreens Boots Alliance Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 12th. Investors of record on Wednesday, August 21st will be given a dividend of $0.25 per share. The ex-dividend date of this dividend is Wednesday, August 21st. This represents a $1.00 dividend on an annualized basis and a yield of 9.28%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is -14.84%.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.